Arcenas, R.C. 2017. Diagnostic Molecular Pathology.
Macedo, Danielle Filho, Adriano José Maia Chaves Soares de Sousa, Caren Nádia Quevedo, João Barichello, Tatiana Júnior, Hélio Vitoriano Nobre and Freitas de Lucena, David 2017. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness. Journal of Affective Disorders, Vol. 208, p. 22.
Marra, Alexandre R. Edmond, Michael B. Ford, Bradley A. Herwaldt, Loreen A. Algwizani, Abdullah R. and Diekema, Daniel J. 2017. Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting. Infection Control & Hospital Epidemiology, Vol. 38, Issue. 01, p. 109.
Agha, Aya Sehgal, Alison Lim, Matthew J. Weber, David Hou, Jing-Zhou Farah, Rafic Raptis, Anastasios Im, Annie Dorritie, Kathleen Marks, Stanley Agha, Mounzer and Lim, Seah H. 2016. Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant. American Journal of Hematology, Vol. 91, Issue. 3, p. 291.
Buonomo, Erica L. and Petri, William A. 2016. The microbiota and immune response during Clostridium difficile infection. Anaerobe, Vol. 41, p. 79.
Dellinger, E. Patchen 2016. Prevention of Hospital-Acquired Infections. Surgical Infections, Vol. 17, Issue. 4, p. 422.
Dowle, Chris 2016. Faecal microbiota transplantation: a review of FMT as an alternative treatment forClostridium difficileinfection. Bioscience Horizons, Vol. 9, p. hzw007.
Eissa, Ahmed G. Blaxland, James A. Williams, Rhodri O. Metwally, Kamel A. El-Adl, Sobhy M. Lashine, El-Sayed M. Baillie, Leslie W. J. and Simons, Claire 2016. Targeting methionyl tRNA synthetase: design, synthesis and antibacterial activity against Clostridium difficile of novel 3-biaryl-N-benzylpropan-1-amine derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 31, Issue. 6, p. 1694.
Garey, Kevin W. Aitken, Samuel L. Gschwind, Liliane Goddu, Sumana Xie, Yang Duff, Catherine Barbut, Frédéric Shah, Dhara N. and DuPont, Herbert L. 2016. Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire. Journal of Clinical Gastroenterology, Vol. 50, Issue. 8, p. 631.
Gerding, Dale N. File, Thomas M. and McDonald, L. Clifford 2016. Diagnosis and Treatment of Clostridium difficile Infection. Infectious Diseases in Clinical Practice, Vol. 24, Issue. 1, p. 3.
Gweon, Tae-Geun Kim, Jinsu Lim, Chul-Hyun Park, Jae Myung Lee, Dong-Gun Lee, In Seok Cho, Young-Seok Kim, Sang Woo and Choi, Myung-Gyu 2016. Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe ComplicatedClostridium difficileInfection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country. Gastroenterology Research and Practice, Vol. 2016, p. 1.
Jackson, Melissa Olefson, Sidney Machan, Jason T. and Kelly, Colleen R. 2016. A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection. Journal of Clinical Gastroenterology, Vol. 50, Issue. 9, p. 742.
Jasiak, Natalia M. Alaniz, Cesar Rao, Krishna Veltman, Katherine and Nagel, Jerod L. 2016. Recurrent Clostridium difficile infection in intensive care unit patients. American Journal of Infection Control, Vol. 44, Issue. 1, p. 36.
Kelly, Sean G. Yarrington, Michael Zembower, Teresa R. Sutton, Sarah H. Silkaitis, Christina Postelnick, Michael Mikolajczak, Anessa and Bolon, Maureen K. 2016. Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics. Infection Control & Hospital Epidemiology, Vol. 37, Issue. 12, p. 1395.
Padua, David and Pothoulakis, Charalabos 2016. Novel approaches to treatingClostridium difficile-associated colitis. Expert Review of Gastroenterology & Hepatology, Vol. 10, Issue. 2, p. 193.
Patel, I. Wungjiranirun, M. Theethira, T. Villafuerte-Galvez, J. Castillo, N. Akbari, M. Alonso, C. D. Leffler, D. A. and Kelly, C. P. 2016. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality. Journal of Antimicrobial Chemotherapy, p. dkw423.
Raghunathan, Vikram M. Sheng, Iris and Lim, Seah H. 2016. Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation. Journal of Translational Medicine, Vol. 14, Issue. 1,
Reeves, Jeffrey S. Evans, Martin E. Simbartl, Loretta A. Kralovic, Stephen M. Kelly, Allison A. Jain, Rajiv and Roselle, Gary A. 2016. Clostridium difficile Infections in Veterans Health Administration Long-Term Care Facilities. Infection Control & Hospital Epidemiology, Vol. 37, Issue. 03, p. 295.
Schwab, E. M. Wilkes, J. Korgenski, K. Hersh, A. L. Pavia, A. T. and Stevens, V. W. 2016. Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients. Hospital Pediatrics, Vol. 6, Issue. 6, p. 339.
Shah, D.N. Aitken, S.L. Barragan, L.F. Bozorgui, S. Goddu, S. Navarro, M.E. Xie, Y. DuPont, H.L. and Garey, K.W. 2016. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. Journal of Hospital Infection, Vol. 93, Issue. 3, p. 286.
We sought to determine the burden of nosocomial Clostridium difficile infection in comparison to other healthcare-associated infections (HAIs) in community hospitals participating in an infection control network. Our data suggest that C. difficilehas replaced MRSA as the most common etiology of HAI in community hospitals in the southeastern United States.
This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
Email your librarian or administrator to recommend adding this journal to your organisation's collection.